First Time Loading...

Eurofins Scientific SE
PAR:ERF

Watchlist Manager
Eurofins Scientific SE Logo
Eurofins Scientific SE
PAR:ERF
Watchlist
Price: 57.66 EUR 0.66% Market Closed
Updated: May 10, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

10.9B
+6%
Assets
Growth Rates:
1 Year
+8%
3 Years
+27%
5 Years
+51%
7 Years
+164%
10 Years
+627%
5.8B
+9%
Liabilities
Growth Rates:
1 Year
+10%
3 Years
+19%
5 Years
+28%
7 Years
+132%
10 Years
+424%
5.1B
+2%
Equity
Growth Rates:
1 Year
+6%
3 Years
+38%
5 Years
+90%
7 Years
+212%
10 Years
+1 210%

Balance Sheet Decomposition
Eurofins Scientific SE

10.9B
Assets
5.8B
Liabilities
10.9B
Assets
5.8B
Liabilities
Current Assets 3.1B
Cash & Short-Term Investments 1.2B
Receivables 1.5B
Other Current Assets 346.4m
Non-Current Assets 7.8B
Long-Term Investments 83.6m
PP&E 2.3B
Intangibles 5.3B
Other Non-Current Assets 93.8m
Current Liabilities 2.1B
Accounts Payable 600.2m
Accrued Liabilities 59.2m
Other Current Liabilities 1.5B
Non-Current Liabilities 3.7B
Long-Term Debt 3.3B
Other Non-Current Liabilities 363.8m

Balance Sheet
Eurofins Scientific SE

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
217
794
826
820
506
297
912
515
487
1 221
Cash
143
203
506
153
25
293
904
498
432
749
Cash Equivalents
74
591
320
667
482
4
9
17
54
472
Total Receivables
365
514
606
827
1 043
1 185
1 389
1 581
1 597
1 617
Accounts Receivables
308
422
498
667
807
1 001
1 194
1 389
1 342
1 381
Other Receivables
57
92
108
160
236
184
196
192
256
237
Inventory
25
38
40
52
66
79
157
154
146
139
Other Current Assets
15
79
108
128
89
43
60
69
84
89
Total Current Assets
621
1 424
1 579
1 827
1 705
1 604
2 518
2 319
2 313
3 066
PP&E Net
324
428
507
686
1 018
1 594
1 575
1 830
2 168
2 297
PP&E Gross
324
428
507
686
1 018
1 594
1 575
1 830
2 168
2 297
Accumulated Depreciation
492
654
736
976
1 133
1 578
1 770
2 191
2 569
2 622
Intangible Assets
194
351
383
735
947
918
825
896
919
796
Goodwill
679
1 412
1 585
2 505
3 418
3 609
3 524
4 115
4 524
4 551
Long-Term Investments
26
47
38
50
73
55
57
82
84
84
Other Long-Term Assets
30
38
38
30
44
44
77
91
76
94
Other Assets
679
1 412
1 585
2 505
3 418
3 609
3 524
4 115
4 524
4 551
Total Assets
1 873
N/A
3 700
+98%
4 129
+12%
5 832
+41%
7 205
+24%
7 823
+9%
8 576
+10%
9 332
+9%
10 084
+8%
10 889
+8%
Liabilities
Accounts Payable
127
197
230
206
232
232
279
323
347
339
Accrued Liabilities
163
242
279
436
561
624
797
875
844
320
Short-Term Debt
2
3
1
234
372
320
17
80
78
0
Current Portion of Long-Term Debt
71
211
45
320
19
135
221
174
135
601
Other Current Liabilities
89
122
158
256
267
272
383
404
367
861
Total Current Liabilities
452
775
710
1 452
1 451
1 582
1 696
1 856
1 772
2 122
Long-Term Debt
638
1 497
1 340
1 662
2 766
3 087
2 917
2 500
3 112
3 326
Deferred Income Tax
42
94
84
126
139
125
115
124
134
110
Minority Interest
8
123
129
39
53
60
26
30
69
60
Other Liabilities
77
254
238
110
128
132
130
176
215
194
Total Liabilities
1 217
N/A
2 742
+125%
2 502
-9%
3 389
+35%
4 536
+34%
4 985
+10%
4 885
-2%
4 685
-4%
5 301
+13%
5 811
+10%
Equity
Common Stock
2
2
2
2
2
2
2
2
2
2
Retained Earnings
326
273
902
1 458
1 614
1 697
2 853
3 543
3 926
3 995
Treasury Stock
0
0
0
0
0
0
0
4
14
55
Other Equity
328
683
724
984
1 054
1 140
835
1 107
869
1 136
Total Equity
656
N/A
957
+46%
1 627
+70%
2 443
+50%
2 669
+9%
2 839
+6%
3 690
+30%
4 648
+26%
4 782
+3%
5 078
+6%
Total Liabilities & Equity
1 873
N/A
3 700
+98%
4 129
+12%
5 832
+41%
7 205
+24%
7 823
+9%
8 576
+10%
9 332
+9%
10 084
+8%
10 889
+8%
Shares Outstanding
Common Shares Outstanding
152
154
169
176
178
179
191
192
193
192

See Also

Summary
ERF intrinsic value, competitors valuation, and company profile.
DCF Valuation
ERF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ERF stock valuation using valuation multiples.
Wall Street Estimates
ERF price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ERF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.